Restricted accessCase reportFirst published online 2024-9
Emtricitabine/tenofovir alafenamide and doravirine in a virologically suppressed adult with HIV and on chronic ambulatory peritoneal dialysis: A case report
Data supporting the safe and effective use of first-line antiretroviral therapy in people living with HIV on hemodialysis or peritoneal dialysis remains limited. Previously in this journal, the first case report of BIC/FTC/TAF use in chronic ambulatory peritoneal dialysis was presented. We present the first known case of DOR + FTC/TAF in chronic ambulatory peritoneal dialysis.
GreenbergKIPerazellaMAAttaMG. HIV and HCV medications in end-stage renal disease. Semin Dial2015; 28(4): 397–403. DOI: 10.1111/sdi.12367.
2.
PartoshDShermanEMEckardtPA, et al.Bictegravir/emtricitabine/tenofovir alafenamide in a virologically suppressed adult with HIV and end-stage renal disease on chronic peritoneal dialysis: a case report. Int J STD AIDS2023; 34(2): 139–141. DOI: 10.1177/09564624221140949.
3.
What to start: initial combination regimens for the antiretroviral-naive patient | Clinicalinfo.HIV.gov
4.
SparkesTLemonovichTLAST Infectious Diseases Community of Practice. Interactions between anti-infective agents and immunosuppressants-guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant2019; 33(9): e13510. DOI: 10.1111/ctr.13510.
5.
Pifeltro (doravirine) [Package Insert]. Rahway, NJ: Merck and Co, 2018
6.
Biktarvy (Bictegravir, emtricitabine and tenofovir alafenamide) [Package Insert]. Foster City, CA: Gilead Sciences, Inc., 2018
7.
Descovy (emtricitabine and tenofovir alafenamide) [Package Insert]. Foster City, CA: Gilead Sciences, Inc., 2022
